NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp
NASDAQ · Healthcare · Medical - Devices · US
$0.96
−7.56%Price chart
Sep 17Sep 22Sep 25Sep 30Oct 5Oct 8Oct 13Oct 16
Key dataOct 16, 2026
Open$1.02
From 52W high−83.65%
Volume94101.00
Market cap$8.75M
P/E (TTM)—
P/S (TTM)0.9x
Div yield—
Key dataOct 16, 2026
Open
$1.02
From 52W high
−83.65%
Volume
94101.00
Market cap
$8.75M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−1.0x
P/E (TTM)
—
RSI (14)
30.9
MomentumView details →
1D Return
−7.56%
YTD Return
−77.86%
SummaryUpdated Jun 1, 2026
NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) is a medical technology company founded in 2014 and headquartered in Eden Prairie, Minnesota. The company went public in March 2018 and specializes in developing innovative thin-film electrode technologies for treating neurological disorders. NeuroOne has evolved from a research-stage company to a commercialized medical device manufacturer, with its flagship OneRF ablation system receiving FDA clearance in 2024. The company has established strategic partnerships with major medical device companies, most notably Zimmer Biomet, to distribute its products globally.
Similar companies
Latest newsMore news →
NeuroOne Medical Technologies reported preliminary FY2026 revenue of $10.5 million, up 15.6% year over year, with Q4 revenue of $3.8 million, up 38.4%.11d agoNeuroOne Medical Technologies secured a record $4.5 million purchase order.11d agoNeuroOne Medical Technologies reported Q3 2026 revenue of $1.97 million, up 16% year-over-year, with a net loss of $2.0 million and diluted EPS of -$0.28.65d ago